Intchains Group
ICG
The9 Ltd
NCTY
Hive Blockchain
HIVE
Canaan
CAN
Coinbase
COIN
US Stock MarketDetailed Quotes
XENE Xenon Pharmaceuticals
- 34.900
- -1.550-4.25%
Close Mar 25 16:00 ET
- 34.900
- 0.0000.00%
Post 16:27 ET
2.67BMarket Cap-11.59P/E (TTM)
36.510High34.590Low375.16KVolume35.540Open36.450Pre Close13.18MTurnover0.53%Turnover RatioLossP/E (Static)76.54MShares46.00052wk High3.54P/B2.47BFloat Cap33.27052wk Low--Dividend TTM70.78MShs Float50.990Historical High--Div YieldTTM5.27%Amplitude2.100Historical Low35.128Avg Price1Lot Size
About Xenon Pharmaceuticals Company
Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.
Company Profile
SymbolXENE
Company NameXenon Pharmaceuticals
Listing DateNov 5, 2014
Issue Price9.00
Founded1996
CEOMr. Ian C. Mortimer
MarketNASDAQ
Employees327
Fiscal Year Ends12-31
Address3650 Gilmore Way,Suite 200
CityBurnaby
ProvinceBritish Columbia
CountryCanada
Zip CodeV5G 4W8
Phone1-604-484-3300
Websitehttp://www.xenon-pharma.com
Company Executives
- Name
- Position
- Salary
- Ian C. Mortimer
- Director, Chief Executive Officer and President
- 9.77M
- Sherry Aulin
- Chief Financial Officer and Principal Accounting Officer
- 3.52M
- Christopher John Kenney
- Chief Medical Officer
- 3.58M
- Andrea DiFabio
- Chief Legal Officer and Corporate Secretary
- --
- Dr. Robin Sherrington, PhD
- Executive Vice President, Strategy and Innovation
- 2.37M
- James R. Empfield
- Executive Vice President, Drug Discovery
- --
- Dawn A. Svoronos
- Chairman of the Board
- 588.37K
- Gary Patou, M.D.
- Independent Director
- 560.09K
- Steven Gannon
- Independent Director
- 561.42K
- Dr. Elizabeth A. Garofalo, M.D.
- Independent Director
- 548.57K
- Justin David Gover
- Independent Director
- 770.91K
- Patrick C. Machado, J.D.
- Independent Director
- 559.58K
- Dr. Gillian M. Cannon, PhD
- Independent Director
- 770.91K
Market Insights
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.